The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon


Work +617 570 1000
Fax +617 523 1231

Joseph Johnson III

Work +1 617 570 1633




Joe Johnson is a partner in Goodwin Procter’s Business Law Department and chair of its M&A/Corporate Governance Practice. Mr. Johnson advises clients, which include public and private companies, investment funds, and institutional investors, in mergers and acquisitions, investments in public and private issuers, and a variety of corporate governance matters.


J.D., 1986 Boston College Law School (summa cum laude) B.A., 1983 Vassar College (cum laude)

United States: M&A/corporate and commercial

Commercial deals and contracts

Within: Commercial deals and contracts

Considered by clients to have ‘strong business acumen’ and ‘practical advice’, Goodwin’s ‘very reliable and trustworthy’ team excels in transactions in the pharmaceutical and technology sectors. In New York, Jeffrey Klein advised Elysium Health on negotiations regarding a service agreement with a media company. In Boston, Robert Puopolo acted for Ginkgo Bioworks in a $100m agreement with Bayer regarding the development of a new company. The team is jointly headed by Joseph Johnson and Mark Macenka in Boston.

[back to top]

Corporate governance

Within: Corporate governance

Goodwin handles shareholder activism matters for existing management. Joseph Johnson in Boston is a key contact - he advised Cognizant Technology Solutions on a co-operation agreement with Elliot Management. Anthony McCusker in Menlo Park handles third-party tender offer defense campaigns.

[back to top]

M&A: middle-market ($500m-999m)

Within: Leading lawyers

Joseph Johnson III - Goodwin

Within: M&A: middle-market ($500m-999m)

Goodwin advises both buyers and sellers in transactions, including asset deals, stock deals, mergers, joint ventures and bankruptcy deals, and has longstanding experience in the technology, life sciences, business services, real estate, financial services and healthcare sectors. The firm also has a robust private equity practice. It advised EPR Properties on its acquisition of CNL Lifestyle Properties, together with co-buyer Och-Ziff Real Estate; and acted for biotechnology company Delinia in its sale to Celgene Corporation, which planned to expand its inflammation and immunology pipeline with Delinia’s preclinical-stage regulatory T cell therapy. Large deal matters included acting for biopharmaceutical services company PAREXEL International in its sale to Pamplona Capital Management; and assisting Albany Molecular Research with its sale to affiliates of The Carlyle Group and GTCR. Boston-based Mark Bettencourt advises private and public companies in the software, internet, digital media, robotics, communications, and networking equipment and information services industries; and Stuart Cable currently serves as chair of the M&A and corporate finance practices for the firm’s technology and life science business units. Other highly rated Boston practitioners include Joseph Johnson III, John Egan III, John Haggerty and John LeClaire. Silicon Valley-based Lawrence Chu, Joshua Klatzkin in Washington DC, Andrew Weidhaas, who divides his time between Los Angeles and New York, and Los Angeles-based Stephen Lee are also experienced practitioners.

[back to top]

Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to